CORAVAS GOLD 20

CORAVAS-GOLD 20 (Atorvastatin 20 mg + Clopidogrel 75 mg + Aspirin 75 mg) Capsule is an advanced triple-action cardiovascular therapy designed for patients requiring intensive heart protection. This triple-action formula works by lowering "bad" cholesterol (atorvastatin) and preventing the formation of harmful blood clots (clopidogrel and aspirin), effectively improving  intensive heart health and other atherosclerotic complications. It combines a lipid-lowering agent with dual antiplatelet therapy to offer complete heart care in a single convenient dose.This formulation helps control cholesterol levels while preventing platelet aggregation and clot formation, thereby reducing the risk of arterial blockage. It is widely used in patients with established cardiovascular disease or those at high risk of thrombotic events. They are commonly prescribed for high-risk patients to manage hyperlipidemia and cardiovascular health.

Atorvastatin helps in reducing bad cholesterol, as it belongs to the group of lipid-lowering medications. Atorvastatin and aspirin salt offer a thinning of blood, and Clopidogrel Bisulphate salt is better known to prevent the blood clot deposits.

How Does CORAVAS-GOLD 20 (Atorvastatin 20 mg + Clopidogrel 75 mg + Aspirin 75 mg ) Work?

Atorvastatin (Statin): Inhibits the enzyme HMG-CoA reductase in the liver, which plays a central role in producing cholesterol. This reduces total cholesterol and LDL ("bad" cholesterol) and raises HDL ("good" cholesterol).

Clopidogrel Bisulphate (Antiplatelet): A prodrug that, when converted to its active metabolite, irreversibly inhibits the binding of Adenosine Diphosphate (ADP) to its P2Y12 platelet receptor, preventing platelet aggregation (clotting).

Aspirin (Antiplatelet): Irreversibly blocks the enzyme cyclooxygenase-1 (COX-1) within platelets, preventing the synthesis of thromboxane A2, a substance that causes platelets to clump together.

This triple mechanism ensures cholesterol control along with powerful dual antiplatelet action for enhanced cardiovascular protection.

Clinical Benefits

This triple-action formula combines a statin (Atorvastatin) with dual antiplatelet therapy (Aspirin and Clopidogrel) to manage lipid levels while preventing clots.

It is crucial for patients with a history of acute coronary syndrome (ACS), myocardial infarction (heart attack), or stroke to prevent subsequent, often fatal, events.

Atorvastatin reduces LDL and triglycerides while improving high-density lipoprotein (HDL) levels, which helps stabilize plaque within the arteries.

Aspirin and Clopidogrel act via different pathways to prevent platelet aggregation and inhibit the formation of harmful blood clots.

By decreasing blood viscosity and reducing plaque, this combination maintains smooth blood flow to the heart and brain.

Dosage & Administration

CORAVAS-GOLD 20 (Atorvastatin 20 mg + Clopidogrel 75 mg + Aspirin 75 mg) Take this medicine in the dose and duration as advised by your doctor , based on the patient’s clinical condition and response to therapy. It is usually administered once daily and can be taken with or without food. Regular monitoring of the lipid profile is recommended to ensure optimal treatment outcomes and dose adjustment if required.

Disclaimer

Use only as prescribed by a healthcare professional. Not suitable for patients with active liver disease or during pregnancy and lactation. Regular monitoring is advised. Do not exceed the recommended dose. Keep out of reach of children and store in a cool, dry place.Patients should report any unusual muscle pain, weakness, or symptoms promptly.